Publications

Wilhelm O, Jordan C, Kek H, Brunton-O'Sullivan MM, Rikard-Bell L, Ramanathan P, Chung AW, Poumbourios P, Wines BD, Jaworowski A, Hearps AC. Afucosylated broadly neutralizing antibodies targeting the HIV envelope elicit enhanced NK-cell-mediated cytotoxicity against HIV-infected CD4+ T-cell and macrophage targets. J Leukoc Biol. 2025 May 7;117(5):qiaf033. doi: 10.1093/jleuko/qiaf033. PMID: 40086815; PMCID: PMC12080361. 

Quang C, Anderson J, Russell FM, Reyburn R, Ratu T, Tuivaga E, Devi R, Frazer IH, Garland SM, Wines B, Hogarth PM, Mulholland K, Chung AW, Toh ZQ, Licciardi PV. Systems serology analysis shows IgG1 and IgG3 memory responses six years after one dose of quadrivalent HPV vaccine. Nat Commun. 2025 Mar 3;16(1):2130. doi: 10.1038/s41467-025-57443-z. PMID: 40032823; PMCID: PMC11876628. 

Aurelia LC, Purcell RA, Theisen RM, Kelly A, Esterbauer R, Ramanathan P, Lee WS, Wines BD, Hogarth PM, Juno JA, Allen LF, Bond KA, Williamson DA, Trevillyan JM, Trubiano JA, Nguyen TH, Kedzierska K, Wheatley AK, Kent SJ, Arnold KB, Selva KJ, Chung AW. Increased SARS-CoV-2 IgG4 has variable consequences dependent upon Fc function, Fc receptor polymorphism, and viral variant. Sci Adv. 2025 Feb 28;11(9):eads1482. doi: 10.1126/sciadv.ads1482. Epub 2025 Feb 26. PMID: 40009690; PMCID: PMC11864192. 

Messina NL, Germano S, Chung AW, van de Sandt CE, Stevens NE, Allen LF, Bonnici R, Croda J, Counoupas C, Grubor-Bauk B, Haycroft ER, Kedzierska K, McDonald E, McElroy R, Netea MG, Novakovic B, Perrett KP, Pittet LF, Purcell RA, Subbarao K, Triccas JA, Lynn DJ, Curtis N; BRACE Trial Consortium Group. Effect of Bacille Calmette-Guérin vaccination on immune responses to SARS-CoV-2 and COVID-19 vaccination. Clin Transl Immunology. 2025 Jan 25;14(1):e70023. doi: 10.1002/cti2.70023. PMID: 39872402; PMCID: PMC11761716. 

Lee WS, Selva KJ, Audsley J, Kent HE, Reynaldi A, Schlub TE, Cromer D, Khoury DS, Peck H, Aban M, Vu MN, Zheng MZ, Chung AW, Koutsakos M, Tan HX, Wheatley AK, Juno JA, Rockman S, Davenport MP, Barr I, Kent SJ. Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccines. JCI Insight. 2025 Jan 9;10(4):e187075. doi: 10.1172/jci.insight.187075. PMID: 39786918; PMCID: PMC11949032. 

Grobben M, Bakker M, Schriek AI, Levels LJJ, Umotoy JC, Tejjani K, van Breemen MJ, Lin RN, de Taeye SW, Ozorowski G, Kootstra NA, Ward AB, Kent SJ, Hogarth PM, Wines BD, Sanders RW, Chung AW, van Gils MJ. Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression. PLoS Pathog. 2024 Dec 11;20(12):e1012739. doi: 10.1371/journal.ppat.1012739. PMID: 39661636; PMCID: PMC11634010. 

Marchese AM, Fries L, Beyhaghi H, Vadivale M, Zhu M, Cloney-Clark S, Plested JS, Chung AW, Dunkle LM, Kalkeri R. Mechanisms and implications of IgG4 responses to SARS-CoV-2 and other repeatedly administered vaccines. J Infect. 2024 Dec;89(6):106317. doi: 10.1016/j.jinf.2024.106317. Epub 2024 Oct 16. PMID: 39419185. 

Jia JZ, Cohen CA, Gu H, McLean MR, Varadarajan R, Bhandari N, Peiris M, Leung GM, Poon LLM, Tsang T, Chung AW, Cowling BJ, Leung NHL, Valkenburg SA. Author Correction: Influenza antibody breadth and effector functions are immune correlates from acquisition of pandemic infection of children. Nat Commun. 2024 Sep 19;15(1):8227. doi: 10.1038/s41467-024-52572-3. Erratum for: Nat Commun. 2024 Apr 13;15(1):3210. doi: 10.1038/s41467-024-47590-0. PMID: 39300094; PMCID: PMC11412989. 

Walker IS, Dini S, Aitken EH, Damelang T, Hasang W, Alemu A, Jensen ATR, Rambhatla JS, Opi DH, Duffy MF, Takashima E, Harawa V, Tsuboi T, Simpson JA, Mandala W, Taylor TE, Seydel KB, Chung AW, Rogerson SJ. A systems serology approach to identifying key antibody correlates of protection from cerebral malaria in Malawian children. BMC Med. 2024 Sep 12;22(1):388. doi: 10.1186/s12916-024-03604-8. PMID: 39267089; PMCID: PMC11396342. 

Lorenz N, McGregor R, Whitcombe AL, Sharma P, Ramiah C, Middleton F, Baker MG, Martin WJ, Wilson NJ, Chung AW, Moreland NJ. An acute rheumatic fever immune signature comprising inflammatory markers, IgG3, and Streptococcus pyogenes-specific antibodies. iScience. 2024 Jul 20;27(8):110558. doi: 10.1016/j.isci.2024.110558. PMID: 39184444; PMCID: PMC11342286. 

Aurelia LC, Purcell RA, Chung AW. Identification of IgG1 and IgG3 Allotypes by PCR and Sanger Sequencing. Methods Mol Biol. 2024;2826:201-218. doi: 10.1007/978-1-0716-3950-4_15. PMID: 39017895. 

Lee WS, Audsley J, Trieu MC, Reynaldi A, Aurelia LC, Mehta PH, Patterson J, Kent HE, Nguyen J, Amarasena T, Esterbauer R, Haycroft ER, Ramanathan P, Davenport MP, Schlub TE, Sasadeusz J, Wheatley AK, Chung AW, Juno JA, Selva KJ, Kent SJ. Randomized controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine. J Clin Invest. 2024 Jul 11;134(17):e181244. doi: 10.1172/JCI181244. PMID: 38990644; PMCID: PMC11364387. 

Quang C, Chung AW, Kemp TJ, Ratu T, Tuivaga E, Russell FM, Licciardi PV, Toh ZQ. Development of a human papillomavirus (HPV) multiplex immunoassay to profile HPV antibodies. J Med Virol. 2024 Jun;96(6):e29732. doi: 10.1002/jmv.29732. PMID: 38874202. 

Wu M, Zhang X, Karunaratne S, Lee JH, Lampugnani ER, Selva KJ, Chung AW, Mueller SN, Chinnery HR, Downie LE. Intravital Imaging of the Human Cornea Reveals the Differential Effects of Season on Innate and Adaptive Immune Cell Morphodynamics. Ophthalmology. 2024 Oct;131(10):1185-1195. doi: 10.1016/j.ophtha.2024.04.020. Epub 2024 May 3. PMID: 38703795. 

Jia JZ, Cohen CA, Gu H, McLean MR, Varadarajan R, Bhandari N, Peiris M, Leung GM, Poon LLM, Tsang T, Chung AW, Cowling BJ, Leung NHL, Valkenburg SA. Influenza antibody breadth and effector functions are immune correlates from acquisition of pandemic infection of children. Nat Commun. 2024 Apr 13;15(1):3210. doi: 10.1038/s41467-024-47590-0. Erratum in: Nat Commun. 2024 Sep 19;15(1):8227. doi: 10.1038/s41467-024-52572-3. PMID: 38615070; PMCID: PMC11016072. 

Purcell RA, Aurelia LC, Esterbauer R, Allen LF, Bond KA, Williamson DA, Trevillyan JM, Trubiano JA, Juno JJ, Wheatley AK, Davenport MP, Nguyen TH, Kedzierska K, Kent SJ, Selva KJ, Chung AW. Immunoglobulin G genetic variation can confound assessment of antibody levels via altered binding to detection reagents. Clin Transl Immunology. 2024 Feb 29;13(3):e1494. doi: 10.1002/cti2.1494. PMID: 38433763; PMCID: PMC10902689. 

Kalkeri R, Zhu M, Cloney-Clark S, Plested JS, Parekh A, Gorinson D, Cai R, Mahato S, Ramanathan P, Aurelia LC, Selva KJ, Marchese AM, Fries L, Chung AW, Dunkle LM. Altered IgG4 antibody response to repeated mRNA versus recombinant protein SARS-CoV-2 vaccines. J Infect. 2024 Mar;88(3):106119. doi: 10.1016/j.jinf.2024.106119. Epub 2024 Feb 13. PMID: 38360356. 

Kalkeri R, Zhu M, Cloney-Clark S, Plested JS, Parekh A, Gorinson D, Cai R, Mahato S, Ramanathan P, Aurelia LC, Selva KJ, Marchese AM, Fries L, Chung AW, Dunkle LM. Altered IgG4 Antibody Response to Repeated mRNA versus Protein COVID Vaccines. medRxiv [Preprint]. 2024 Jan 18:2024.01.17.24301374. doi: 10.1101/2024.01.17.24301374. Update in: J Infect. 2024 Mar;88(3):106119. doi: 10.1016/j.jinf.2024.106119. PMID: 38293205; PMCID: PMC10827267. 

Haycroft ER, Damelang T, Lopez E, Rodgers MA, Wines BD, Hogarth M, Ameel CL, Kent SJ, Scanga CA, O'Connor SL, Chung AW. Antibody glycosylation correlates with disease progression in SIV-Mycobacterium tuberculosis coinfected cynomolgus macaques. Clin Transl Immunology. 2023 Nov 20;12(11):e1474. doi: 10.1002/cti2.1474. PMID: 38020728; PMCID: PMC10660403. 

Nolan TM, Deliyannis G, Griffith M, Braat S, Allen LF, Audsley J, Chung AW, Ciula M, Gherardin NA, Giles ML, Gordon TP, Grimley SL, Horng L, Jackson DC, Juno JA, Kedzierska K, Kent SJ, Lewin SR, Littlejohn M, McQuilten HA, Mordant FL, Nguyen THO, Soo VP, Price B, Purcell DFJ, Ramanathan P, Redmond SJ, Rockman S, Ruan Z, Sasadeusz J, Simpson JA, Subbarao K, Fabb SA, Payne TJ, Takanashi A, Tan CW, Torresi J, Wang JJ, Wang LF, Al-Wassiti H, Wong CY, Zaloumis S, Pouton CW, Godfrey DI. Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster. EBioMedicine. 2023 Dec;98:104878. doi: 10.1016/j.ebiom.2023.104878. Epub 2023 Nov 27. PMID: 38016322; PMCID: PMC10696466.

Selva KJ, Ramanathan P, Haycroft ER, Reynaldi A, Cromer D, Tan CW, Wang LF, Wines BD, Hogarth PM, Downie LE, Davis SK, Purcell RA, Kent HE, Juno JA, Wheatley AK, Davenport MP, Kent SJ, Chung AW. Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections. JCI Insight. 2023 Sep 22;8(18):e172470. doi: 10.1172/jci.insight.172470. PMID: 37737263; PMCID: PMC10561726. 

Selva KJ, Ramanathan P, Haycroft ER, Tan CW, Wang LF, Downie LE, Davis SK, Purcell RA, Kent HE, Juno JA, Wheatley AK, Davenport MP, Kent SJ, Chung AW. Mucosal antibody responses following Vaxzevria vaccination. Immunol Cell Biol. 2023 Sep 5. doi: 10.1111/imcb.12685. Epub ahead of print. PMID: 37670482. 

Haycroft ER, Davis SK, Ramanathan P, Lopez E, Purcell RA, Tan LL, Pymm P, Wines BD, Hogarth PM, Wheatley AK, Juno JA, Redmond SJ, Gherardin NA, Godfrey DI, Tham WH, Selva KJ, Kent SJ, Chung AW. Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants. Med Microbiol Immunol. 2023 Aug;212(4):291-305. doi: 10.1007/s00430-023-00773-w. Epub 2023 Jul 21. PMID: 37477828; PMCID: PMC10372118.

Chia WN, Tan CW, Tan AWK, Young B, Starr TN, Lopez E, Fibriansah G, Barr J, Cheng S, Yeoh AY, Yap WC, Lim BL, Ng TS, Sia WR, Zhu F, Chen S, Zhang J, Kwek MSS, Greaney AJ, Chen M, Au GG, Paradkar PN, Peiris M, Chung AW, Bloom JD, Lye D, Lok S, Wang LF. Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor. Sci Adv. 2023 Jul 28;9(30):eade3470. doi: 10.1126/sciadv.ade3470. Epub 2023 Jul 26. PMID: 37494438; PMCID: PMC10371021. 

Carrera J, Aktepe TE, Earnest L, Christiansen D, Wheatley AK, Tan HX, Chung AW, Collett S, McPherson K, Torresi J, Mackenzie JM, Simmons CP. Adenovirus vector produced Zika virus-like particles induce a long-lived neutralising antibody response in mice. Vaccine. 2023 Jul 25;41(33):4888-4898. doi: 10.1016/j.vaccine.2023.06.068. Epub 2023 Jun 28. PMID: 37391311.

Purcell RA, Theisen RM, Arnold KB, Chung AW, Selva KJ. Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations. Front Immunol. 2023 Jun 27;14:1183727. doi: 10.3389/fimmu.2023.1183727. PMID: 37600816; PMCID: PMC10433199. 

Zhang W, Rowntree LC, Muttucumaru R, Damelang T, Aban M, Hurt AC, Auladell M, Esterbauer R, Wines B, Hogarth M, Turner SJ, Wheatley AK, Kent SJ, Patil S, Avery S, Morrissey O, Chung AW, Koutsakos M, Nguyen TH, Cheng AC, Kotsimbos TC, Kedzierska K. Robust immunity to influenza vaccination in haematopoietic stem cell transplant recipients following reconstitution of humoral and adaptive immunity. Clin Transl Immunology. 2023 Jun 27;12(6):e1456. doi: 10.1002/cti2.1456. PMID: 37383182; PMCID: PMC10294294.

Zhang W, Kedzierski L, Chua BY, Mayo M, Lonzi C, Rigas V, Middleton BF, McQuilten HA, Rowntree LC, Allen LF, Purcell RA, Tan HX, Petersen J, Chaurasia P, Mordant F, Pogorelyy MV, Minervina AA, Crawford JC, Perkins GB, Zhang E, Gras S, Clemens EB, Juno JA, Audsley J, Khoury DS, Holmes NE, Thevarajan I, Subbarao K, Krammer F, Cheng AC, Davenport MP, Grubor-Bauk B, Coates PT, Christensen B, Thomas PG, Wheatley AK, Kent SJ, Rossjohn J, Chung AW, Boffa J, Miller A, Lynar S, Nelson J, Nguyen THO, Davies J, Kedzierska K. Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities. Nat Immunol. 2023 Jun;24(6):966-978. doi: 10.1038/s41590-023-01508-y. Epub 2023 May 29. PMID: 37248417; PMCID: PMC10232372.

Deliyannis G, Gherardin NA, Wong CY, Grimley SL, Cooney JP, Redmond SJ, Ellenberg P, Davidson KC, Mordant FL, Smith T, Gillard M, Lopez E, McAuley J, Tan CW, Wang JJ, Zeng W, Littlejohn M, Zhou R, Fuk-Woo Chan J, Chen ZW, Hartwig AE, Bowen R, Mackenzie JM, Vincan E, Torresi J, Kedzierska K, Pouton CW, Gordon TP, Wang LF, Kent SJ, Wheatley AK, Lewin SR, Subbarao K, Chung AW, Pellegrini M, Munro T, Nolan T, Rockman S, Jackson DC, Purcell DFJ, Godfrey DI. Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine. EBioMedicine. 2023 Jun;92:104574. doi: 10.1016/j.ebiom.2023.104574. Epub 2023 May 4. PMID: 37148585; PMCID: PMC10159263. 

Habel JR, Chua BY, Kedzierski L, Selva KJ, Damelang T, Haycroft ER, Nguyen TH, Koay HF, Nicholson S, McQuilten HA, Jia X, Allen LF, Hensen L, Zhang W, van de Sandt CE, Neil JA, Pragastis K, Lau JS, Jumarang J, Allen EK, Amanant F, Krammer F, Wragg KM, Juno JA, Wheatley AK, Tan HX, Pell G, Walker S, Audsley J, Reynaldi A, Thevarajan I, Denholm JT, Subbarao K, Davenport MP, Hogarth PM, Godfrey DI, Cheng AC, Tong SY, Bond K, Williamson DA, McMahon JH, Thomas PG, Pannaraj PS, James F, Holmes NE, Smibert OC, Trubiano JA, Gordon CL, Chung AW, Whitehead CL, Kent SJ, Lappas M, Rowntree LC, Kedzierska K. Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbations. JCI Insight. 2023 Apr 10;8(7):e167157. doi: 10.1172/jci.insight.167157. PMID: 37036008; PMCID: PMC10132165.  

Wines BD, Kurtovic L, Trist HM, Esparon S, Lopez E, Chappin K, Chan LJ, Mordant FL, Lee WS, Gherardin NA, Patel SK, Hartley GE, Pymm P, Cooney JP, Beeson JG, Godfrey DI, Burrell LM, van Zelm MC, Wheatley AK, Chung AW, Tham WH, Subbarao K, Kent SJ, Hogarth PM. Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2. Front Immunol. 2023 Jan 10;13:1122516. doi: 10.3389/fimmu.2022.1122516. Erratum for: A corrigendum on Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2. by Wines BD, Kurtovic L, Trist HM, Esparon S, Lopez E, Chappin K, Chan L-J, Mordant FL, Lee WS, Gherardin NA, Patel SK, Hartley GE, Pymm P, Cooney JP, Beeson JG, Godfrey DI, Burrell LM, van Zelm MC, Wheatley AK, Chung AW, Tham W-H, Subbarao K, Kent SJ and Hogarth PM (2022) Front. Immunol. 13:889372. doi: 10.3389/fimmu.2022.889372. PMID: 36703991; PMCID: PMC9872783.  

Kassa MW, Hasang W, Barateiro A, Damelang T, Brewster J, Dombrowski JG, Longley RJ, Chung AW, Wunderlich G, Mueller I, Aitken EH, Marinho CRF, Rogerson SJ. Acquisition of antibodies to Plasmodium falciparum and Plasmodium vivax antigens in pregnant women living in a low malaria transmission area of Brazil. Malar J. 2022 Dec 1;21(1):360. doi: 10.1186/s12936-022-04402-4. PMID: 36457056; PMCID: PMC9714246. 

Pymm P, Redmond SJ, Dolezal O, Mordant F, Lopez E, Cooney JP, Davidson KC, Haycroft ER, Tan CW, Seneviratna R, Grimley SL, Purcell DFJ, Kent SJ, Wheatley AK, Wang LF, Leis A, Glukhova A, Pellegrini M, Chung AW, Subbarao K, Uldrich AP, Tham WH, Godfrey DI, Gherardin NA. Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2. iScience. 2022 Nov 18;25(11):105259. doi: 10.1016/j.isci.2022.105259. Epub 2022 Oct 4. PMID: 36213007; PMCID: PMC9529347.  

Davis SK, Selva KJ, Lopez E, Haycroft ER, Lee WS, Wheatley AK, Juno JA, Adair A, Pymm P, Redmond SJ, Gherardin NA, Godfrey DI, Tham WH, Kent SJ, Chung AW. Heterologous SARS-CoV-2 IgA neutralising antibody responses in convalescent plasma. Clin Transl Immunology. 2022 Oct 23;11(10):e1424. doi: 10.1002/cti2.1424. PMID: 36299410; PMCID: PMC9588388. 

Chua BY, Sekiya T, Koutsakos M, Nomura N, Rowntree LC, Nguyen THO, McQuilten HA, Ohno M, Ohara Y, Nishimura T, Endo M, Itoh Y, Habel JR, Selva KJ, Wheatley AK, Wines BD, Hogarth PM, Kent SJ, Chung AW, Jackson DC, Brown LE, Shingai M, Kedzierska K, Kida H. Immunization with inactivated whole virus particle influenza virus vaccines improves the humoral response landscape in cynomolgus macaques. PLoS Pathog. 2022 Oct 7;18(10):e1010891. doi: 10.1371/journal.ppat.1010891. PMID: 36206307; PMCID: PMC9581423. 

Quang C, Chung AW, Frazer IH, Toh ZQ, Licciardi PV. Single-dose HPV vaccine immunity: is there a role for non-neutralizing antibodies? Trends Immunol. 2022 Oct;43(10):815-825. doi: 10.1016/j.it.2022.07.011. Epub 2022 Aug 20. PMID: 35995705. 

Ju Y, Lee WS, Pilkington EH, Kelly HG, Li S, Selva KJ, Wragg KM, Subbarao K, Nguyen THO, Rowntree LC, Allen LF, Bond K, Williamson DA, Truong NP, Plebanski M, Kedzierska K, Mahanty S, Chung AW, Caruso F, Wheatley AK, Juno JA, Kent SJ. Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine. ACS Nano. 2022 Aug 23;16(8):11769-11780. doi: 10.1021/acsnano.2c04543. Epub 2022 Jun 27. PMID: 35758934.  

Wines BD, Kurtovic L, Trist HM, Esparon S, Lopez E, Chappin K, Chan LJ, Mordant FL, Lee WS, Gherardin NA, Patel SK, Hartley GE, Pymm P, Cooney JP, Beeson JG, Godfrey DI, Burrell LM, van Zelm MC, Wheatley AK, Chung AW, Tham WH, Subbarao K, Kent SJ, Hogarth PM. Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2. Front Immunol. 2022 Jul 28;13:889372. doi: 10.3389/fimmu.2022.889372. PMID: 35967361; PMCID: PMC9369017.  

Tosif S, Haycroft ER, Sarkar S, Toh ZQ, Do LAH, Donato CM, Selva KJ, Hoq M, Overmars I, Nguyen J, Lee LY, Clifford V, Daley A, Mordant FL, McVernon J, Mulholland K, Marcato AJ, Smith MZ, Curtis N, McNab S, Saffery R, Kedzierska K, Subarrao K, Burgner D, Steer A, Bines JE, Sutton P, Licciardi PV, Chung AW, Neeland MR, Crawford NW. Virology and immune dynamics reveal high household transmission of ancestral SARS-CoV-2 strain. Pediatr Allergy Immunol. 2022 Jul;33(7):10.1111/pai.13824. doi: 10.1111/pai.13824. PMID: 35871459; PMCID: PMC9349415. 

Selva KJ, Chung AW. Insights into how SARS-CoV2 infection induces cytokine storms. Trends Immunol. 2022 Jun;43(6):417-419. doi: 10.1016/j.it.2022.04.007. Epub 2022 May 7. PMID: 35537983; PMCID: PMC9077489. 

Zhang W, Chua BY, Selva KJ, Kedzierski L, Ashhurst TM, Haycroft ER, Shoffner-Beck SK, Hensen L, Boyd DF, James F, Mouhtouris E, Kwong JC, Chua KYL, Drewett G, Copaescu A, Dobson JE, Rowntree LC, Habel JR, Allen LF, Koay HF, Neil JA, Gartner MJ, Lee CY, Andersson P, Khan SF, Blakeway L, Wisniewski J, McMahon JH, Vine EE, Cunningham AL, Audsley J, Thevarajan I, Seemann T, Sherry NL, Amanat F, Krammer F, Londrigan SL, Wakim LM, King NJC, Godfrey DI, Mackay LK, Thomas PG, Nicholson S, Arnold KB, Chung AW, Holmes NE, Smibert OC, Trubiano JA, Gordon CL, Nguyen THO, Kedzierska K. SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity. Nat Commun. 2022 May 19;13(1):2774. doi: 10.1038/s41467-022-30088-y. PMID: 35589689; PMCID: PMC9120039.  

Chalayer E, Gramont B, Zekre F, Goguyer-Deschaumes R, Waeckel L, Grange L, Paul S, Chung AW, Killian M. Fc receptors gone wrong: A comprehensive review of their roles in autoimmune and inflammatory diseases. Autoimmun Rev. 2022 Mar;21(3):103016. doi: 10.1016/j.autrev.2021.103016. Epub 2021 Dec 14. PMID: 34915182. 

Lemke MM, Theisen RM, Bozich ER, McLean MR, Lee CY, Lopez E, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kratochvil S, Wines BD, Hogarth PM, Kent SJ, Chung AW, Arnold KB. A Quantitative Approach to Unravel the Role of Host Genetics in IgG-FcγR Complex Formation After Vaccination. Front Immunol. 2022 Feb 22;13:820148. doi: 10.3389/fimmu.2022.820148. PMID: 35273603; PMCID: PMC8902241. 

Rambhatla JS, Tonkin-Hill GQ, Takashima E, Tsuboi T, Noviyanti R, Trianty L, Sebayang BF, Lampah DA, Marfurt J, Price RN, Anstey NM, Papenfuss AT, Damelang T, Chung AW, Duffy MF, Rogerson SJ. Identifying Targets of Protective Antibodies against Severe Malaria in Papua, Indonesia, Using Locally Expressed Domains of Plasmodium falciparum Erythrocyte Membrane Protein 1. Infect Immun. 2022 Feb 17;90(2):e0043521. doi: 10.1128/IAI.00435-21. Epub 2021 Dec 6. PMID: 34871039; PMCID: PMC8853675. 

Walker IS, Chung AW, Damelang T, Rogerson SJ. Analysis of Antibody Reactivity to Malaria Antigens by Microsphere-Based Multiplex Immunoassay. Methods Mol Biol. 2022;2470:309-325. doi: 10.1007/978-1-0716-2189-9_23. PMID: 35881355.  

Di Pietro A, Polmear J, Cooper L, Damelang T, Hussain T, Hailes L, O'Donnell K, Udupa V, Mi T, Preston S, Shtewe A, Hershberg U, Turner SJ, La Gruta NL, Chung AW, Tarlinton DM, Scharer CD, Good-Jacobson KL. Targeting BMI-1 in B cells restores effective humoral immune responses and controls chronic viral infection. Nat Immunol. 2022 Jan;23(1):86-98. doi: 10.1038/s41590-021-01077-y. Epub 2021 Nov 29. PMID: 34845392. 

Grobben M, van der Straten K, Brouwer PJ, Brinkkemper M, Maisonnasse P, Dereuddre-Bosquet N, Appelman B, Lavell AA, van Vught LA, Burger JA, Poniman M, Oomen M, Eggink D, Bijl TP, van Willigen HD, Wynberg E, Verkaik BJ, Figaroa OJ, de Vries PJ, Boertien TM; Amsterdam UMC COVID-19 S3/HCW study group; Bomers MK, Sikkens JJ, Le Grand R, de Jong MD, Prins M, Chung AW, de Bree GJ, Sanders RW, van Gils MJ. Cross-reactive antibodies after SARS-CoV-2 infection and vaccination. Elife. 2021 Nov 23;10:e70330. doi: 10.7554/eLife.70330. PMID: 34812143; PMCID: PMC8610423. 

McLean MR, Wragg KM, Lopez E, Kiazyk SA, Ball TB, Bueti J, Kent SJ, Juno JA, Chung AW. Serological and cellular inflammatory signatures in end-stage kidney disease and latent tuberculosis. Clin Transl Immunology. 2021 Nov 5;10(11):e1355. doi: 10.1002/cti2.1355. PMID: 34765193; PMCID: PMC8569694. 

Selva KJ, Davis SK, Haycroft ER, Lee WS, Lopez E, Reynaldi A, Davenport MP, Kent HE, Juno JA, Chung AW, Kent SJ. Tear antibodies to SARS-CoV-2: implications for transmission. Clin Transl Immunology. 2021 Nov 1;10(11):e1354. doi: 10.1002/cti2.1354. PMID: 34754451; PMCID: PMC8559894. 

Wheatley AK, Pymm P, Esterbauer R, Dietrich MH, Lee WS, Drew D, Kelly HG, Chan LJ, Mordant FL, Black KA, Adair A, Tan HX, Juno JA, Wragg KM, Amarasena T, Lopez E, Selva KJ, Haycroft ER, Cooney JP, Venugopal H, Tan LL, O Neill MT, Allison CC, Cromer D, Davenport MP, Bowen RA, Chung AW, Pellegrini M, Liddament MT, Glukhova A, Subbarao K, Kent SJ, Tham WH. Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain. Cell Rep. 2021 Oct 12;37(2):109822. doi: 10.1016/j.celrep.2021.109822. Epub 2021 Sep 25. PMID: 34610292; PMCID: PMC8463300. 

Hensen L, Nguyen THO, Rowntree LC, Damelang T, Koutsakos M, Aban M, Hurt A, Harland KL, Auladell M, van de Sandt CE, Everitt A, Blacker C, Oyong DA, Loughland JR, Webb JR, Wines BD, Hogarth PM, Flanagan KL, Plebanski M, Wheatley A, Chung AW, Kent SJ, Miller A, Clemens EB, Doherty PC, Nelson J, Davies J, Tong SYC, Kedzierska K. Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians. Proc Natl Acad Sci U S A. 2021 Oct 12;118(41):e2109388118. doi: 10.1073/pnas.2109388118. PMID: 34607957; PMCID: PMC8522271. 

Chappell KJ, Mordant FL, Li Z, Wijesundara DK, Ellenberg P, Lackenby JA, Cheung STM, Modhiran N, Avumegah MS, Henderson CL, Hoger K, Griffin P, Bennet J, Hensen L, Zhang W, Nguyen THO, Marrero-Hernandez S, Selva KJ, Chung AW, Tran MH, Tapley P, Barnes J, Reading PC, Nicholson S, Corby S, Holgate T, Wines BD, Hogarth PM, Kedzierska K, Purcell DFJ, Ranasinghe C, Subbarao K, Watterson D, Young PR, Munro TP. Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial. Lancet Infect Dis. 2021 Oct;21(10):1383-1394. doi: 10.1016/S1473-3099(21)00200-0. Epub 2021 Apr 19. PMID: 33887208; PMCID: PMC8055208. 

Lemke MM, McLean MR, Lee CY, Lopez E, Bozich ER, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kratochvil S, Wines BD, Hogarth PM, Kent SJ, Chung AW, Arnold KB. A systems approach to elucidate personalized mechanistic complexities of antibody-Fc receptor activation post-vaccination. Cell Rep Med. 2021 Sep 1;2(9):100386. doi: 10.1016/j.xcrm.2021.100386. PMID: 34622227; PMCID: PMC8484512.

Zhang W, Chua B, Selva K, Kedzierski L, Ashhurst T, Haycroft E, Shoffner S, Hensen L, Boyd D, James F, Mouhtouris E, Kwong J, Chua K, Drewett G, Copaescu A, Dobson J, Rowntree L, Habel J, Allen L, Koay HF, Neil J, Gartner M, Lee C, Andersson P, Seemann T, Sherry N, Amanat F, Krammer F, Londrigan S, Wakim L, King N, Godfrey D, Mackay L, Thomas P, Nicholson S, Arnold K, Chung A, Holmes N, Smibert O, Trubiano J, Gordon C, Nguyen T, Kedzierska K. Immune responses in COVID-19 respiratory tract and blood reveal mechanisms of disease severity. Res Sq [Preprint]. 2021 Aug 26:rs.3.rs-802084. doi: 10.21203/rs.3.rs-802084/v1. Update in: Nat Commun. 2022 May 19;13(1):2774. PMID: 34462740; PMCID: PMC8404907. 

Lopez E, Haycroft ER, Adair A, Mordant FL, O'Neill MT, Pymm P, Redmond SJ, Lee WS, Gherardin NA, Wheatley AK, Juno JA, Selva KJ, Davis SK, Grimley SL, Harty L, Purcell DF, Subbarao K, Godfrey DI, Kent SJ, Tham WH, Chung AW. Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay. JCI Insight. 2021 Aug 23;6(16):e150012. doi: 10.1172/jci.insight.150012. PMID: 34251356; PMCID: PMC8409985. 

Aitken, E. H.*, T. Damelang, A*. Ortega-Pajares*, A. Alemu, W. Hasang, S. Dini, H. W. Unger, M. Ome-Kaius, M. A. Nielsen, A. Salanti, J. Smith, S. Kent, P. M. Hogarth, B. D. Wines, J. A. Simpson, A. W. Chung* and S. J. Rogerson* (2021). "Developing a multivariate prediction model of antibody features associated with protection of malaria-infected pregnant women from placental malaria." Elife 

Lee, W. S.*, K. J. Selva*, S. K. Davis*, B. D. Wines, A. Reynaldi, R. Esterbauer, H. G. Kelly, E. R. Haycroft, H. X. Tan, J. A. Juno, A. K. Wheatley, P. M. Hogarth, D. Cromer, M. P. Davenport, A. W. Chung* and S. J. Kent* (2021). "Decay of Fc-dependent antibody functions after mild to moderate COVID-19." Cell Rep Med 2(6): 100296.

Selva, K. J.*, C. E. van de Sandt*, M. M. Lemke*, C. Y. Lee*, S. K. Shoffner*, B. Y. Chua, S. K. Davis, T. H. O. Nguyen, L. C. Rowntree, L. Hensen, M. Koutsakos, C. Y. Wong, F. Mordant, D. C. Jackson, K. L. Flanagan, J. Crowe, S. Tosif, M. R. Neeland, P. Sutton, P. V. Licciardi, N. W. Crawford, A. C. Cheng, D. L. Doolan, F. Amanat, F. Krammer, K. Chappell, N. Modhiran, D. Watterson, P. Young, W. S. Lee, B. D. Wines, P. Mark Hogarth, R. Esterbauer, H. G. Kelly, H. X. Tan, J. A. Juno, A. K. Wheatley, S. J. Kent, K. B. Arnold, K. Kedzierska* and A. W. Chung* (2021). "Systems serology detects functionally distinct coronavirus antibody features in children and elderly." Nat Commun 12(1): 2037.

Chappell, K. J., F. L. Mordant, Z. Li, D. K. Wijesundara, P. Ellenberg, J. A. Lackenby, S. T. M. Cheung, N. Modhiran, M. S. Avumegah, C. L. Henderson, K. Hoger, P. Griffin, J. Bennet, L. Hensen, W. Zhang, T. H. O. Nguyen, S. Marrero-Hernandez, K. J. Selva, A. W. Chung, M. H. Tran, P. Tapley, J. Barnes, P. C. Reading, S. Nicholson, S. Corby, T. Holgate, B. D. Wines, P. M. Hogarth, K. Kedzierska, D. F. J. Purcell, C. Ranasinghe, K. Subbarao, D. Watterson, P. R. Young and T. P. Munro (2021). "Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial." Lancet Infect Dis. 

Pymm, P., A. Adair, L. J. Chan, J. P. Cooney, F. L. Mordant, C. C. Allison, E. Lopez, E. R. Haycroft, M. T. O'Neill, L. L. Tan, M. H. Dietrich, D. Drew, M. Doerflinger, M. A. Dengler, N. E. Scott, A. K. Wheatley, N. A. Gherardin, H. Venugopal, D. Cromer, M. P. Davenport, R. Pickering, D. I. Godfrey, D. F. J. Purcell, S. J. Kent, A. W. Chung, K. Subbarao, M. Pellegrini, A. Glukhova and W. H. Tham (2021). "Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice." Proc Natl Acad Sci U S A 118(19).

Rowntree, L. C., B. Y. Chua, S. Nicholson, M. Koutsakos, L. Hensen, C. Douros, K. Selva, F. L. Mordant, C. Y. Wong, J. R. Habel, W. Zhang, X. Jia, L. Allen, D. L. Doolan, D. C. Jackson, A. K. Wheatley, S. J. Kent, F. Amanat, F. Krammer, K. Subbarao, A. C. Cheng, A. W. Chung, M. Catton, T. H. Nguyen, C. E. van de Sandt and K. Kedzierska (2021). "Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features." Clin Transl Immunology 10(3): e1258.

Wheatley, A. K., J. A. Juno, J. J. Wang, K. J. Selva, A. Reynaldi, H. X. Tan, W. S. Lee, K. M. Wragg, H. G. Kelly, R. Esterbauer, S. K. Davis, H. E. Kent, F. L. Mordant, T. E. Schlub, D. L. Gordon, D. S. Khoury, K. Subbarao, D. Cromer, T. P. Gordon, A. W. Chung, M. P. Davenport and S. J. Kent (2021). "Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19." Nat Commun 12(1): 1162 

Damelang, T., E. H. Aitken, W. Hasang, E. Lopez, M. Killian, H. W. Unger, A. Salanti, A. Shub, E. McCarthy, K. Kedzierska, M. Lappas, S. J. Kent, S. J. Rogerson and A. W. Chung (2021). "Antibody mediated activation of natural killer cells in malaria exposed pregnant women." Sci Rep 11(1): 4130.

Koutsakos, M., L. C. Rowntree, L. Hensen, B. Y. Chua, C. E. van de Sandt, J. R. Habel, W. Zhang, X. Jia, L. Kedzierski, T. M. Ashhurst, G. H. Putri, F. Marsh-Wakefield, M. N. Read, D. N. Edwards, E. B. Clemens, C. Y. Wong, F. L. Mordant, J. A. Juno, F. Amanat, J. Audsley, N. E. Holmes, C. L. Gordon, O. C. Smibert, J. A. Trubiano, C. M. Hughes, M. Catton, J. T. Denholm, S. Y. C. Tong, D. L. Doolan, T. C. Kotsimbos, D. C. Jackson, F. Krammer, D. I. Godfrey, A. W. Chung, N. J. C. King, S. R. Lewin, A. K. Wheatley, S. J. Kent, K. Subbarao, J. McMahon, I. Thevarajan, T. H. O. Nguyen, A. C. Cheng and K. Kedzierska (2021). "Integrated immune dynamics define correlates of COVID-19 severity and antibody responses." Cell Rep Med 2(3): 100208.

Muenchhoff, M.*, A. W. Chung*, J. Roider*, A. S. Dugast, S. Richardson, H. Kloverpris, A. Leslie, T. Ndung'u, P. Moore, G. Alter and P. J. R. Goulder (2020). "Distinct Immunoglobulin Fc Glycosylation Patterns Are Associated with Disease Nonprogression and Broadly Neutralizing Antibody Responses in Children with HIV Infection." mSphere 5(6).

Tosif, S., M. R. Neeland, P. Sutton, P. V. Licciardi, S. Sarkar, K. J. Selva, L. A. H. Do, C. Donato, Z. Quan Toh, R. Higgins, C. Van de Sandt, M. M. Lemke, C. Y. Lee, S. K. Shoffner, K. L. Flanagan, K. B. Arnold, F. L. Mordant, K. Mulholland, J. Bines, K. Dohle, D. G. Pellicci, N. Curtis, S. McNab, A. Steer, R. Saffery, K. Subbarao, A. W. Chung, K. Kedzierska, D. P. Burgner and N. W. Crawford (2020). "Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19." Nat Commun 11(1): 5703.

Fisher KL, Mabuka J, Sivro A, Passmore JS, Osman F, Ndlovu, Karim QA, Karim SS, Chung AW, Baxter C, Archary D. Topical tenofovir pre-exposure prophylaxis and mucosal HIV- specific Fc-mediated antibody activities in women. Front Immuno. 2020 Jul. 

Nguyen CN, Chung AW, Lopez E, Silvers J, Kent HE, Kent SJ, Downie LE Meibomian gland dropout is associated with immunodeficiency at HIV diagnosis: Implications for dry eye disease. Ocul Surf. 2020 Apr;18(2):206-213. doi: 10.1016/j.jtos.2020.02.003

Chung AW Multifaceted roles of antibody Fc effector functions: from protection to pathology Immunol Cell Biol. 2020 Apr ;98(4):251-252. doi: 10.1111/imcb.12330. 

Chung AW, Ho TK, Hanson-Manful P, Tritscheller S, Raynes JM, Whitcombe AL, Tay ML, McGregor R, Lorenz N, Oliver JR, Gurney JK, Print CG, Wilson NJ, Martin WJ, Williamson DA, Baker MG, Moreland NJ. Systems immunology reveals a linked IgG3-C4 response in patients with acute rheumatic fever. Immunol Cell Biol. 2020 Jan;98(1):12-21. doi: 10.1111/imcb.12298. Epub 2019 Nov 18.

McLean MR, Lu LL, Kent SJ, Chung AW. An Inflammatory Story: Antibodies in Tuberculosis Comorbidities. Front Immunol. 2019 Dec 9;10:2846. doi: 10.3389/fimmu.2019.02846. eCollection 2019. Review.

 Davis SK, Selva KJ, Kent SJ, Chung AW. Serum IgA Fc effector functions in infectious disease and cancer. Immunol Cell Biol. 2019 Nov 29. doi: 10.1111/imcb.12306.

Lopez E, Scott NE, Wines BD, Hogarth PM, Wheatley AK, Kent SJ, Chung AW. Low pH Exposure During Immunoglobulin G Purification Methods Results in Aggregates That Avidly Bind Fcγ Receptors: Implications for Measuring Fc Dependent Antibody Functions.Front Immunol. 2019 Oct 11;10:2415. doi: 10.3389/fimmu.2019.02415. eCollection 2019. 

Selva KJ, Juno JA, Worley MJ, Chung AW, Tachedjian G, Kent SJ, Parsons MS. Short Communication: Effect of Seminal Plasma on Functions of Monocytes and Granulocytes. AIDS Res Hum Retroviruses. 2019 Jun;35(6):553-556. doi: 10.1089/AID.2018.0219.

Damelang T, Rogerson SJ, Kent SJ, Chung AW. Role of IgG3 in Infectious Diseases. Trends Immunol. 2019 Mar;40(3):197-211. doi: 10.1016/j.it.2019.01.005. Epub 2019 Feb 10. Review.

Jegaskanda S, Vanderven HA, Tan HX, Alcantara S, Wragg KM, Parsons MS, Chung AW, Juno JA, Kent SJ. Influenza Virus Infection Enhances Antibody-Mediated NK Cell Functions via Type I Interferon-Dependent Pathways. J Virol. 2019 Feb 19;93(5). pii: e02090-18. doi: 10.1128/JVI.02090-18. Print 2019 Mar 1.

Parsons MS, Chung AW, Kent SJ. Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies. Retrovirology. 2018 Aug 22;15(1):58. doi: 10.1186/s12977-018-0438-x. Review.

Lopez E, Shattock RJ, Kent SJ, Chung AW. The Multifaceted Nature of Immunoglobulin A and Its Complex Role in HIV. AIDS Res Hum Retroviruses. 2018 Sep;34(9):727-738. doi: 10.1089/AID.2018.0099. Epub 2018 Aug 27. Review.

Cheeseman HM, Day S, McFarlane LR, Fleck S, Miller A, Cole T, Sousa-Santos N, Cope A, Cizmeci D, Tolazzi M, Hwekwete E, Hannaman D, Kratochvil S, McKay PF, Chung AW, Kent SJ, Cook A, Scarlatti G, Abraham S, Combadiere B, McCormack S, Lewis DJ, Shattock RJ. Combined Skin and Muscle DNA Priming Provides Enhanced Humoral Responses to a Human Immunodeficency Virus Type 1 Clade C Envelope Vaccine. Hum Gene Ther. 2018 Sep;29(9):1011-1028. doi: 10.1089/hum.2018.075.

Richardson SI, Chung AW, Natarajan H, Mabvakure B, Mkhize NN, Garrett N, Abdool Karim S, Moore PL, Ackerman ME, Alter G, Morris L. HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies. PLoS Pathog. 2018 Apr 9;14(4):e1006987. doi: 10.1371/journal.ppat.1006987. eCollection 2018 Apr. 

Chung AW*, Mabuka JM*, Ndlovu B, Licht A, Robinson H, Ramlakhan Y, Ghebremichael M, Reddy T, Goulder PJR, Walker BD, Ndung'u T, Alter G. Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity. AIDS. 2018 Jun 19;32(10):1207-1217. doi: 10.1097/QAD.0000000000001812.

Worley MJ, Fei K, Lopez-Denman AJ, Kelleher AD, Kent SJ, Chung AW. Neutrophils mediate HIV-specific antibody-dependent phagocytosis and ADCC. J Immunol Methods. 2018 Jun;457:41-52. doi: 10.1016/j.jim.2018.03.007. Epub 2018 Mar 29.

Kratochvil S, McKay PF, Chung AW, Kent SJ, Gilmour J, Shattock RJ. Corrigendum: Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination. Front Immunol. 2018 Feb 27;9:342. doi: 10.3389/fimmu.2018. 00342. eCollection 2018.

Koutsakos M, Wheatley AK, Loh L, Clemens EB, Sant S, Nüssing S, Fox A, Chung AW, Laurie KL, Hurt AC, Rockman S, Lappas M, Loudovaris T, Mannering SI, Westall GP, Elliot M, Tangye SG, Wakim LM, Kent SJ, Nguyen THO, Kedzierska K. Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity. Sci Transl Med. 2018 Feb 14;10(428). pii: eaan8405. doi: 10.1126/scitranslmed.aan8405.

Kratochvil S, McKay PF, Chung AW, Kent SJ, Gilmour J, Shattock RJ. Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination. Front Immunol. 2017 Dec 20;8:1883. doi: 10.3389/fimmu.2017.01883. eCollection 2017. Erratum in: Front Immunol. 2018 Feb 27;9:342. 

Chung AW, Alter G. Systems serology: profiling vaccine induced humoral immunity against HIV. Retrovirology. 2017 Dec 21;14(1):57. doi: 10.1186/s12977-017-0380-3. Review.

Sadanand S*, Das J*, Chung AW*, Schoen MK, Lane S, Suscovich TJ, Streeck H, Smith DM, Little SJ, Lauffenburger DA, Richman DD, Alter G. Temporal variation in HIV-specific IgG subclass antibodies during acute infection differentiates spontaneous controllers from chronic progressors. AIDS. 2018 Feb 20;32(4):443-450. doi: 10.1097/QAD.0000000000 001716.

Kent SJ, Chung AW. A Role for Fc-Mediated Humoral Immunity in Reducing HIV Transmission Rates between HIV Serodiscordant Heterosexual Couples. EBioMedicine. 2017 Dec;26:2-3. doi: 10.1016/j.ebiom.2017.11.011. Epub 2017 Nov 16.

Arnold KB*, Chung AW*. Prospects from systems serology research. Immunology. 2018 Mar;153(3):279-289. doi: 10.1111/imm.12861. Epub 2017 Dec 1. Review.

Vanderven HA, Jegaskanda S, Wines BD, Hogarth PM, Carmuglia S, Rockman S, Chung AW, Kent SJ. Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older Adults. J Infect Dis. 2017 Dec 27;217(1):12-23. doi: 10.1093/infdis/jix554.

Madhavi V, Wines BD, Amin J, Emery S; ENCORE1 Study Group, Lopez E, Kelleher A; Sydney LTNP Study Group, Center RJ, Hogarth PM, Chung AW*, Kent SJ*, Stratov I.* HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV. J Virol. 2017 Aug 24;91(18). pii: e00700-17. doi: 10.1128/JVI.00700-17. Print 2017 Sep 15. 

McLean MR, Madhavi V, Wines BD, Hogarth PM, Chung AW*, Kent SJ*. Dimeric Fcγ Receptor Enzyme-Linked Immunosorbent Assay To Study HIV-Specific Antibodies: A New Look into Breadth of Fcγ Receptor Antibodies Induced by the RV144 Vaccine Trial. J Immunol. 2017 Jul 15;199(2):816-826. doi: 10.4049/jimmunol.1602161. Epub 2017 Jun 14. 

Kratochvil S, McKay PF, Kopycinski JT, Bishop C, Hayes PJ, Muir L, Pinder CL, Cizmeci D, King D, Aldon Y, Wines BD, Hogarth PM, Chung AW, Kent SJ, Held K, Geldmacher C, Dally L, Santos NS, Cole T, Gilmour J, Fidler S, Shattock RJ. A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens. Front Immunol. 2017 May 24;8:595. doi: 10.3389/fimmu.2017.00595. eCollection 2017.

Lu LL*, Chung AW*, Rosebrock TR*, Ghebremichael M, Yu WH, Grace PS, Schoen MK, Tafesse F, Martin C, Leung V, Mahan AE, Sips M, Kumar MP, Tedesco J, Robinson H, Tkachenko E, Draghi M, Freedberg KJ, Streeck H, Suscovich TJ, Lauffenburger DA, Restrepo BI, Day C, Fortune SM, Alter G. A Functional Role for Antibodies in Tuberculosis. Cell. 2016 Oct 6;167(2):433-443.e14. doi: 10.1016/j.cell.2016.08.072. Epub 2016 Sep 22. 

Garcia-Beltran WF, Hölzemer A, Martrus G, Chung AW, Pacheco Y, Simoneau CR, Rucevic M, Lamothe-Molina PA, Pertel T, Kim TE, Dugan H, Alter G, Dechanet-Merville J, Jost S, Carrington M, Altfeld M. Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1. Nat Immunol. 2016 Sep;17(9):1067-74. doi: 10.1038/ni.3513. Epub 2016 Jul 25.

Mahan AE, Jennewein MF, Suscovich T, Dionne K, Tedesco J, Chung AW, Streeck H, Pau M, Schuitemaker H, Francis D, Fast P, Laufer D, Walker BD, Baden L, Barouch DH, Alter G. Correction: Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination. PLoS Pathog. 2016 Jun 2;12(6):e1005694. doi: 10.1371/journal.ppat.1005694. eCollection 2016 Jun. 

Vaccari M, Gordon SN, Fourati S, Schifanella L, Liyanage NP, Cameron M, Keele BF, Shen X, Tomaras GD, Billings E, Rao M, Chung AW, Dowell KG, Bailey-Kellogg C, Brown EP, Ackerman ME, Vargas-Inchaustegui DA, Whitney S, Doster MN, Binello N, Pegu P, Montefiori DC, Foulds K, Quinn DS, Donaldson M, Liang F, Loré K, Roederer M, Koup RA, McDermott A, Ma ZM, Miller CJ, Phan TB, Forthal DN, Blackburn M, Caccuri F, Bissa M, Ferrari G, Kalyanaraman V, Ferrari MG, Thompson D, Robert-Guroff M, Ratto-Kim S, Kim JH, Michael NL, Phogat S, Barnett SW, Tartaglia J, Venzon D, Stablein DM, Alter G, Sekaly RP, Franchini G. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016 Jul;22(7):762-70. doi: 10.1038/nm.4105. Epub 2016 May 30. Erratum in: Nat Med. 2016 Oct 6;22(10 ):1192.

Mahan AE, Jennewein MF, Suscovich T, Dionne K, Tedesco J, Chung AW, Streeck H, Pau M, Schuitemaker H, Francis D, Fast P, Laufer D, Walker BD, Baden L, Barouch DH, Alter G. Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination. PLoS Pathog. 2016 Mar 16;12(3):e1005456. doi: 10.1371/journal.ppat.1005456. eCollection 2016 Mar. Erratum in: PLoS Pathog. 2016 Jun;12(6):e1005694. 

Hölzemer A, Thobakgale CF, Jimenez Cruz CA, Garcia-Beltran WF, Carlson JM, van Teijlingen NH, Mann JK, Jaggernath M, Kang SG, Körner C, Chung AW, Schafer JL, Evans DT, Alter G, Walker BD, Goulder PJ, Carrington M, Hartmann P, Pertel T, Zhou R, Ndung'u T, Altfeld M. Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa. PLoS Med. 2015 Nov 17;12(11):e1001900; discussion e1001900. doi: 10.1371/journal.pmed.1001 900. eCollection 2015 Nov. 

Chung AW*, Kumar MP*, Arnold KB*, Yu WH, Schoen MK, Dunphy LJ, Suscovich TJ, Frahm N, Linde C, Mahan AE, Hoffner M, Streeck H, Ackerman ME, McElrath MJ, Schuitemaker H, Pau MG, Baden LR, Kim JH, Michael NL, Barouch DH, Lauffenburger DA, Alter G. Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology. Cell. 2015 Nov 5;163(4):988-98. doi: 10.1016/j.cell.2015.10.027. 

Choi I, Chung AW, Suscovich TJ, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, O'Connell RJ, Francis D, Robb ML, Michael NL, Kim JH, Alter G, Ackerman ME, Bailey-Kellogg C. Machine learning methods enable predictive modeling of antibody feature:function relationships in RV144 vaccinees. PLoS Comput Biol. 2015 Apr 13;11(4):e1004185. doi: 10.1371/journal.pcbi.1004185. eCollection 2015 Apr. 

Chung AW, Crispin M, Pritchard L, Robinson H, Gorny MK, Yu X, Bailey-Kellogg C, Ackerman ME, Scanlan C, Zolla-Pazner S, Alter G. Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function. AIDS. 2014 Nov 13;28(17):2523-30. doi: 10.1097/QAD.0000000000000444. 

Chung AW, Ghebremichael M, Robinson H, Brown E, Choi I, Lane S, Dugast AS, Schoen MK, Rolland M, Suscovich TJ, Mahan AE, Liao L, Streeck H, Andrews C, Rerks-Ngarm S, Nitayaphan S, de Souza MS, Kaewkungwal J, Pitisuttithum P, Francis D, Michael NL, Kim JH, Bailey-Kellogg C, Ackerman ME, Alter G. Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines. Sci Transl Med. 2014 Mar 19;6(228):228ra38. doi: 10.1126/scitranslmed.3007736. 

Chung AW, Alter G. Dissecting the antibody constant region protective immune parameters in HIV infection.  2014. Future Virology 9 (4), 397-414

Madhavi V, Navis M, Chung AW, Isitman G, Wren LH, De Rose R, Kent SJ, Stratov I. Activation of NK cells by HIV-specific ADCC antibodies: role for granulocytes in expressing HIV-1 peptide epitopes. Hum Vaccin Immunother. 2013 May;9(5):1011-8. doi: 10.4161/hv.23446. Epub 2013 Jan 16. 

Wren LH, Chung AW, Isitman G, Kelleher AD, Parsons MS, Amin J, Cooper DA; ADCC study collaboration investigators, Stratov I, Navis M, Kent SJ. Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection. Immunology. 2013 Feb;138(2):116-23. doi: 10.1111/imm.12016. 

Johansson SE, Rollman E, Chung AW, Center RJ, Hejdeman B, Stratov I, Hinkula J, Wahren B, Kärre K, Kent SJ, Berg L. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients. Viral Immunol. 2011 Oct;24(5):359-68. doi: 10.1089/vim.2011.0025. Epub 2011 Sep 29.

Wren LH, Chung AW, Isitman G, Kelleher AD, Parsons MS, Amin J, Cooper DA; ADCC study collaboration investigators, Stratov I, Navis M, Kent SJ. Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection. Immunology. 2013 Feb;138(2):116-23. doi: 10.1111/imm.12016. 

Johansson SE, Rollman E, Chung AW, Center RJ, Hejdeman B, Stratov I, Hinkula J, Wahren B, Kärre K, Kent SJ, Berg L. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients. Viral Immunol. 2011 Oct;24(5):359-68. doi: 10.1089/vim.2011.0025. Epub 2011 Sep 29.

Chung AW, Navis M, Isitman G, Wren L, Silvers J, Amin J, Kent SJ, Stratov I. Activation of NK cells by ADCC antibodies and HIV disease progression. J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):127-31. doi: 10.1097/QAI.0b013e31822c62b9.

Chung AW*, Isitman G*, Navis M, Kramski M, Center RJ, Kent SJ, Stratov I. Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure. Proc Natl Acad Sci U S A. 2011 May 3;108(18):7505-10. doi: 10.1073/pnas.1016048108. Epub 2011 Apr 18.

Chung AW, Navis M, Isitman G, Centre R, Finlayson R, Bloch M, Gelgor L, Kelleher A, Kent SJ, Stratov I. Activation of NK cells by ADCC responses during early HIV infection. Viral Immunol. 2011 Apr;24(2):171-5. doi: 10.1089/vim.2010.0108.

Isitman G, Chung AW, Navis M, Kent SJ, Stratov I. Pol as a target for antibody dependent cellular cytotoxicity responses in HIV-1 infection. Virology. 2011 Mar 30;412(1):110-6. doi: 10.1016/j.virol.2010.12.044. Epub 2011 Jan 26.

Chung AW, Rollman E, Center RJ, Kent SJ, Stratov I. Rapid degranulation of NK cells following activation by HIV-specific antibodies. J Immunol. 2009 Jan 15;182(2):1202-10.

Chung AW, Rollman E, Johansson S, Kent SJ, Stratov I. The utility of ADCC responses in HIV infection. Curr HIV Res. 2008 Nov;6(6):515-9. Review.

Smith MZ, Fernandez CS, Chung A, Dale CJ, De Rose R, Lin J, Brooks AG, Krebs KC, Watkins DI, O'Connor DH, Davenport MP, Kent SJ, The pigtail macaque MHC class I allele Mane-A*10 presents an immundominant SIV Gag epitope: identification, tetramer development and implications of immune escape and reversion. J Med Primatol. 2005 Oct;34(5-6):282-93